# The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers

> **NCT00318201** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 7 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Erythromycin
- **DRUG:** Diltiazem

## Key facts

- **NCT ID:** NCT00318201
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318201, "The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00318201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*